neuroClues
PrivateLast Round
Series A
Apr 7, 2026
Total Funding Raised
$19.24M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
neuroClues is a MedTech company that provides an AI-driven eye-tracking device for clinicians to aid in the early diagnosis of neurological disorders such as Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Medical AI, Computer Vision
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neuroClues Comparables
Compare neuroClues with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroSync | 81% | |
| ViewMind Inc. | 81% | |
| RightEye | 81% | |
neuroClues Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 7, 2026 | ||||
| VC Round | Apr 30, 2024 | ||||
| Grant | Dec 19, 2022 | ||||
| Seed | Nov 8, 2021 |
Key People
Founding team and executive leadership
neuroClues Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| Wallonie Entreprendre | Series A, VC Round, Seed |
| White Fund | Series A, VC Round |
| Nivelinvest | Series A, VC Round, Seed |
| EIC Accelerator | Grant, VC Round |
| Teampact Ventures | Series A |
| LeanSquare | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 19, 54% of headcount.
- Jul 20, 2026
Open roles increased to 19, 54% of headcount.
neuroClues Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about neuroClues's valuation, stock price, and market status.